Adam Robitel
Ask VT AI
View News Summary
- Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
- Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
- Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
- Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
- Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Adam Robitel
News from Adam Robitel
